Related Experiment Video

Updated: Apr 1, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.3K

Statin reduces orbitopathy risk in patients with Graves' disease by modulating apoptosis and autophagy activities

Maurizio Bifulco1, Elena Ciaglia2

  • 1Department of Medicine and Surgery, University of Salerno, Via Salvatore Allende, 84081, Baronissi, Salerno, Italy. maubiful@unisa.it.

Endocrine
|October 7, 2015
PubMed

Insights

Statins may lower the risk of Graves

Area of Science:

  • Endocrinology
  • Immunology
  • Ophthalmology

Background:

  • Graves' disease is an autoimmune disorder affecting the thyroid.
  • Graves' orbitopathy is a common complication of Graves' disease, leading to eye
  • Statins are cholesterol-lowering drugs with potential anti-inflammatory effects.

Purpose of the Study:

  • To investigate the potential protective role of statin use against Graves' orbitopathy.
  • To explore the underlying mechanisms of statin's effect on Graves' orbitopathy, focusing on apoptosis and autophagy.

Main Methods:

  • Observational study analyzing patient data.
  • Statistical analysis to assess the association between statin use and orbitopathy risk.
  • Exploration of cellular pathways involved in the hypothesized mechanism.

Main Results:

  • Statin use was associated with a reduced incidence of Graves' orbitopathy.
  • Preliminary evidence suggests statins may modulate apoptosis and autophagy pathways.

Conclusions:

  • Statin therapy may offer a protective benefit against the development of Graves' orbitopathy.
  • Modulation of apoptosis and autophagy represents a potential mechanism for statin's therapeutic effect in Graves' disease management.
Keywords:
AutophagyGraves’ orbitopathyStatins

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
583
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
5.0K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
9.0K